IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 70 filers reported holding IDERA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $25,993 | -7.2% | 74,267 | 0.0% | 0.00% | – |
Q3 2022 | $28,000 | -17.6% | 74,267 | 0.0% | 0.00% | – |
Q2 2022 | $34,000 | -8.1% | 74,267 | 0.0% | 0.00% | – |
Q1 2022 | $37,000 | -11.9% | 74,267 | 0.0% | 0.00% | – |
Q4 2021 | $42,000 | -44.7% | 74,267 | 0.0% | 0.00% | – |
Q3 2021 | $76,000 | -14.6% | 74,267 | 0.0% | 0.00% | – |
Q2 2021 | $89,000 | -8.2% | 74,267 | -0.1% | 0.00% | – |
Q1 2021 | $97,000 | -51.3% | 74,348 | +36.9% | 0.00% | – |
Q4 2020 | $199,000 | +63.1% | 54,320 | -4.9% | 0.00% | – |
Q3 2020 | $122,000 | +25.8% | 57,143 | +5.4% | 0.00% | – |
Q2 2020 | $97,000 | +34.7% | 54,229 | -0.3% | 0.00% | – |
Q1 2020 | $72,000 | -21.7% | 54,365 | +7.3% | 0.00% | – |
Q4 2019 | $92,000 | -48.6% | 50,668 | -18.0% | 0.00% | – |
Q3 2019 | $179,000 | -71.2% | 61,783 | -73.4% | 0.00% | – |
Q2 2019 | $622,000 | +1.0% | 232,673 | -3.6% | 0.00% | – |
Q1 2019 | $616,000 | -8.6% | 241,444 | -0.7% | 0.00% | – |
Q4 2018 | $674,000 | -68.9% | 243,197 | -0.2% | 0.00% | -100.0% |
Q3 2018 | $2,170,000 | – | 243,612 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 629,340 | $5,607,000 | 0.82% |
Baker Brothers Advisors | 4,833,897 | $43,070,000 | 0.28% |
Kassirer Asset Management Corp | 19,341 | $172,000 | 0.11% |
Virtus ETF Advisers LLC | 34,596 | $308,000 | 0.03% |
Palo Alto Investors LP | 77,044 | $686,000 | 0.03% |
OXFORD ASSET MANAGEMENT LLP | 147,560 | $1,280,000 | 0.03% |
ROPES WEALTH ADVISORS LLC | 12,500 | $111,000 | 0.03% |
Candriam S.C.A. | 195,000 | $1,737,000 | 0.02% |
NATIXIS | 429,816 | $3,830,000 | 0.02% |
Cordasco Financial Network | 1,875 | $17,000 | 0.02% |